TROJANIELLO, CLAUDIA
 Distribuzione geografica
Continente #
AS - Asia 111
NA - Nord America 93
EU - Europa 16
Continente sconosciuto - Info sul continente non disponibili 8
AF - Africa 4
SA - Sud America 4
OC - Oceania 1
Totale 237
Nazione #
US - Stati Uniti d'America 84
SG - Singapore 59
VN - Vietnam 23
CN - Cina 7
HK - Hong Kong 7
JP - Giappone 7
FR - Francia 5
CA - Canada 3
IN - India 3
MX - Messico 3
BD - Bangladesh 2
BR - Brasile 2
DE - Germania 2
GB - Regno Unito 2
IT - Italia 2
JM - Giamaica 2
SC - Seychelles 2
AR - Argentina 1
AU - Australia 1
DZ - Algeria 1
EC - Ecuador 1
GT - Guatemala 1
IQ - Iraq 1
LT - Lituania 1
NL - Olanda 1
NO - Norvegia 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
SE - Svezia 1
ZA - Sudafrica 1
Totale 229
Città #
San Jose 40
Singapore 38
Council Bluffs 11
Ho Chi Minh City 10
Ashburn 7
Tokyo 7
Hong Kong 5
Lauterbourg 5
Hanoi 4
Los Angeles 4
Buffalo 2
Mexico City 2
Montreal 2
Shanghai 2
Ahmedabad 1
Akron 1
Amsterdam 1
Arlington 1
Augusta 1
Baghlia 1
Centro Municipality 1
Clark 1
Clinton 1
Collingwood 1
Delray Beach 1
Duhok 1
Fort Payne 1
Frankfurt am Main 1
General Pico 1
Glasgow 1
Guatemala City 1
Haiphong 1
Hamīrpur 1
Haslet 1
Houston 1
Johannesburg 1
Joinville 1
Kingston 1
Kolkata 1
Lahore 1
New York 1
Northborough 1
Oslo 1
Parma 1
Phoenix 1
Pico Rivera 1
Puyallup 1
Quận Bình Thạnh 1
Riverview 1
Ruston 1
Spartanburg 1
Stockholm 1
Sydney 1
São Paulo 1
Treviso 1
Warsaw 1
Điện Bàn 1
Totale 182
Nome #
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab 50
Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a phase II randomized non-comparative study 42
Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy 41
The features and management of acquired resistance to PD1-based therapy in metastatic melanoma 39
Durability of response to immune checkpoint inhibitors in metastatic Merkel cell carcinoma after treatment cessation 24
Sequencing Targeted and Immune Therapy in BRAF-Mutant Melanoma: Lessons Learned 23
Merkel Cell Polyomavirus and DNA Damage Response (DDR): Transcriptional Analysis of DDR Pathways in the Context of Merkel Cell Carcinoma. 11
CliAnti-PD-1 Combinations: Triplets and Beyond 7
Totale 237
Categoria #
all - tutte 967
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 967


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026193 0 0 0 0 32 33 39 34 34 13 2 6
2026/202744 19 12 13 0 0 0 0 0 0 0 0 0
Totale 237